UKMi Q&A xx - SPS
The exact dose of sublingual atropine has not been established (3,4) and atropine should not be used in patients with cognitive impairment, dementia and hallucinations (3). Further studies are required to determine if, and under what circumstances, sublingual atropine is effective for the management of hypersalivation (4). ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.